Age-related changes in CD4(+)CD25(+)FOXP3(+) regulatory T cells and their relationship with lung cancer

OBJECTIVES: CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) inhibit the anti-tumour immune response and reduce the effect of cancer immunotherapy. Although studies have demonstrated that the number and suppressive activity of Treg increase with age, it is not clear whether these changes correlate wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Pan-Fei, Zhu, Li-Jing, Chen, Xiao-Ying, Qiu, Zhu-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333862/
https://www.ncbi.nlm.nih.gov/pubmed/28253320
http://dx.doi.org/10.1371/journal.pone.0173048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333862/
https://www.ncbi.nlm.nih.gov/pubmed/28253320
http://dx.doi.org/10.1371/journal.pone.0173048

Ejemplares similares